logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9510777 B1

PDFFull Text
Date of Patent:
Dec. 06, 2016

Filed:

Mar. 08, 2013

Monitoring of neuromodulation using biomarkers

Applicant:

Medtronic Ardian Luxembourg S.a.r.l., Luxembourg, LU;

Inventors:

Ayala Hezi-Yamit, Santa Rosa, CA (US);

Rudy Beasley, Santa Rosa, CA (US);

Susan Thornton Edwards, Santa Rosa, CA (US);

Lori Garcia, Santa Rosa, CA (US);

Michele Lee Silver, Santa Rosa, CA (US);

Christopher W. Storment, Santa Rosa, CA (US);

Carol M. Sullivan, Santa Rosa, CA (US);

Joseph A. Traina, Santa Rosa, CA (US);

Stefan Stoyanov Tunev, Santa Rosa, CA (US);

Assignee:

Medtronic Ardian Luxembourg S.a.r.l., Luxembourg, LU;

Attorney:
Primary Examiner:

Christopher D Koharski

Assistant Examiner:

Pamela M Bays

Int. Cl.
CPC ...
A61B 18/18 (2006.01); A61N 1/32 (2006.01); A61B 5/15 (2006.01); A61B 5/157 (2006.01); A61N 1/36 (2006.01); A61B 5/145 (2006.01); A61B 5/00 (2006.01); A61N 1/05 (2006.01); A61B 10/00 (2006.01); A61B 5/20 (2006.01); A61B 18/14 (2006.01); A61B 18/00 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61B 5/1405 (2013.01); A61B 5/14503 (2013.01); A61B 5/14546 (2013.01); A61B 5/157 (2013.01); A61B 5/20 (2013.01); A61B 5/201 (2013.01); A61B 5/4836 (2013.01); A61B 5/6851 (2013.01); A61B 5/6853 (2013.01); A61B 5/6858 (2013.01); A61B 10/0045 (2013.01); A61B 18/1492 (2013.01); A61B 18/18 (2013.01); A61N 1/05 (2013.01); A61N 1/32 (2013.01); A61N 1/3605 (2013.01); A61N 1/36007 (2013.01); A61B 5/15003 (2013.01); A61B 5/150229 (2013.01); A61B 5/150992 (2013.01); A61B 5/4035 (2013.01); A61B 10/007 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00166 (2013.01); A61B 2018/00214 (2013.01); A61B 2018/00279 (2013.01); A61B 2018/00345 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00511 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00642 (2013.01); G01N 33/68 (2013.01); G01N 2800/347 (2013.01);
Abstract

Provided herein are methods, devices, compositions, and kits for monitoring neuromodulation efficacy based on detecting changes in the level or activity of one or more target biomarkers associated with neuromodulation, as well as methods and processes of performing neuromodulation that incorporate monitoring of neuromodulation efficacy based on changes in level or activity of one or more target biomarkers.

Find Patent Forward Citations

Loading…